Use this url to cite publication: https://hdl.handle.net/20.500.12512/12804
Options
Ophthalmic Drug Delivery in Glaucoma—A Review
Type of publication
Straipsnis Scopus duomenų bazėje / Article in Scopus database (S1b)
Title
Ophthalmic Drug Delivery in Glaucoma—A Review
Ingrida Januleviciene, Lina Siaudvytyte, Ruta Barsauskaite
Publisher (trusted)
MDPI
Is Referenced by
Date Issued
Date Issued |
---|
2012 |
Extent
p. 243-251.
Is part of
Pharmaceutics. Basel, Switzerland : MDPI, 2012, vol. 4.
Version
Originalus / Original
Series/Report no.
Review
Field of Science
Keywords
Abstract
Glaucoma is a progressive optic neuropathy and medical therapy is the initial option for the treatment of this potentially blinding condition. Topical instillation of eye drops from the bottle is the most common glaucoma drug delivery form. Due to limited permeability of anterior ocular surface, natural clearance and drainage, eye drops contain large amounts of inactive ingredients. Effective penetration enhancers are known as irritants causing ocular discomfort. Although drug efficacy is determined by active ingredients, inactive agents can affect tolerance and can result in conjunctival irritation and hyperemia and influence patients’ adherence and quality of life.
Type of document
type::text::journal::journal article
ISSN (of the container)
1999-4923
Other Identifier(s)
(LSMU ALMA)990000794280107106
Coverage Spatial
Šveicarija / Switzerland (CH)
Language
Anglų / English (en)
Bibliographic Details
35